2020-2027 Analysis and Review Hematology Probes Market

Hematology Probes Market

Hematology Probes Market By Clinical Application (Blood Cancer, Hematopathology and Others), By End Users (Pathology Laboratories, Research Academia and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

03-06-2020 REP-HC-5105 40 Tables 120 pages Format

The hematology probes market was valued at USD 198.6 Mn by 2019. The growing incidence of blood cancer worldwide primarily drives the hematology probes market growth. Additionally, the rising prevalence of genetic blood malignancies increases the demand for early screening which ultimately leads to the increasing demand for hematology probes market.

Hematology Probes Market

The effective treatment regimen of a patient suffering from blood cancers completely depends on precise genetic tests which further elucidates the disease prognosis and aids in the decision making of an appropriate treatment regimen. The hematology probes are widely employed in detecting different blood malignancies as it dramatically reduces the scanning time, detection of accurate genetic loci, probes are vital in gaining high-resolution images and genetic translocation associated with various hematopoietic disorders. Increasing demand for personalized therapy will further accentuate the hematology probes market growth.

The major segments related to the hematology probes market are: 

By Clinical Application (2017–2027; US$ Mn)

Blood Cancer

Hematopathology

Others

By End Users (2017–2027; US$ Mn)

Pathology Laboratories

Research Academia

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global hematology probes market
  • The overall segmentation of the hematology probes market, by clinical application, end-users, and geography is minutely studied. Blood cancer and pathology laboratories are dominating the clinical application and end-user segments respectively
  • Growing incidence of blood cancer worldwide
  • Rising public health awareness has resulted in early screening and diagnosis for blood malignancies

Report gist?

  • The study of the global hematology probes market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and end-users and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the biopharmaceutical manufacturers actively engaged in the production and marketing of hematology probes due to the  rising prevalence of blood cancer worldwide
  • The report will pathologists engaged in the screening and diagnosis of biological samples for blood malignancies
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to hematology probes market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Blood cancer is currently spearheading the clinical application segment for the hematology probes market. According to the latest research citings provided by the Janssen Pharmaceutica N.V., approximately 900,000 people throughout the globe are suffering from blood cancer. Clinical studies suggest that there are almost 140 different types of blood cancer, which is responsible for 7% of all the cancer cases recorded worldwide. The majority of the patients are diagnosed in the later stages of cancer and hence lack of proper treatment is associated with a huge mortality rate. Hematopathology is going to register steady market growth on account of the rising prevalence of genetic blood disorders such as hemophilia, thalassemia, etc. The clinical investigation is vital in the novel drug development of biomolecules for the treatment of various types of blood malignancies.

Presently, pathology laboratories are leading the end-user segment for the hematology probes market. Rising prevalence of blood malignancies and proactive initiatives adopted by the global healthcare agencies in the early screening and diagnosis of blood cancer drives the market growth. Research academia is expected to showcase comfortable market growth during the forecast period. Increasing demand for biological molecules and immunotherapy for the treatment of various blood disorders proles market growth.

North America is presently dominating the geography segment for the hematology probes market. The rising prevalence of blood cancer primarily drives market growth in the region. According to the latest statistics provided by the Lymphoma and Leukemia Society (LLS), approximately every 3 minutes, 1 person is diagnosed with blood cancer in the United States. Furthermore, the domicile of key players such as Abbott Laboratories., Creative Bioarray, BioGenex, etc. further propels the market growth in the region. Europe is holding the second-largest market in the regional segment for hematology probes on account of the proactive initiatives adopted by the European Medical Agency in the early screening and diagnosis of blood malignancies prevalent in the region. Asia Pacific is anticipated to be the fastest-growing regional segment in the hematology probes market. Constant growth observed in the pathology laboratories and the emergence of local players engaged in the manufacturing of hematology probes together determine the market growth in the region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.